483 Allergan, PLC. Sep 2016

483 Allergan, PLC. Sep 2016

Peter Lenahan FDA$119.00 - Available Now

FDA investigators audited the Allergan, PLC. - Madison, NJ, United States facility and issued inspectional observations (via FDA 483) on 01 Sep 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Sep 2016
  • Location: Madison, United States
  • FEI: 3008162988
Add To Cart